Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 2 | +132K | 100% | $0.92 | +$122K |
Sells | 0 | ||||
Net | +2 | +132K | 100% | +$122K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Baker Bros. Advisors Lp | Director, 10%+ Owner | $56.6M | Jun 14, 2024 | ||
Orbimed Advisors Llc | Director, 10%+ Owner | $38.2M | May 22, 2023 | ||
Krishna Vaddi | CEO, Director | $1.58M | +$99.3K | +6.72% | Dec 18, 2024 |
Jane Huang | President, CMO | $438K | Oct 4, 2024 | ||
Laurent Chardonnet | Chief Financial Officer | $159K | Mar 1, 2024 | ||
Bryant D. Lim | CLO, Interim CFO, Corp Sec. | $24.8K | +$22.6K | +1042% | Dec 19, 2024 |
Christopher Pierce | EVP and Chief of Business Oper | $14.1K | Sep 2, 2021 | ||
Peggy Scherle | Chief Scientific Officer | Mar 1, 2024 | |||
Andrew Combs | Chief Chemistry Officer | Mar 1, 2024 | |||
Deborah Morosini | EVP, Chief of Clinical Affairs | Feb 15, 2022 | |||
Martin Babler | Director | Jun 14, 2024 | |||
Paul A. Friedman | Director | Jun 14, 2024 | |||
Mardi Dier | Director | Jun 14, 2024 | |||
David P. Bonita | Director, 10%+ Owner | Jun 14, 2024 | |||
David J. Mauro | Chief Medical Officer | Oct 5, 2021 | |||
Victor Sandor | Director | Jun 14, 2024 | |||
Brian Piper | Chief Financial Officer | Aug 25, 2021 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|